MedTrace Logo

Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer

NCT03290417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2020-02-18

No results posted yet for this study

Summary

The purpose of this study is to see if eating vitamin D, omega 3 and turmeric (curcumin) slows the growth of prostate cancer in men on active surveillance.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D

5000 IU/cap; One cap by mouth daily

DIETARY_SUPPLEMENT

Omega-3

720 mg/cap; one capsule by mouth 3 times per day

DIETARY_SUPPLEMENT

Turmeric

250mg/cap; two capsules by mouth 4 times per day

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • David Levy, MD · Cleveland Clinic, Case Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-07
Primary Completion
2019-06-20
Completion
2019-12-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03290417 on ClinicalTrials.gov